The α glycolipid rules the NKT cell TCR
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20242099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Mitchell Kronenberg und 1 weiteren Autor:innen. Beteiligte Einrichtung: La Jolla Institute for Immunology , La Jolla, CA, USA. Hauptthemen laut MEDLINE: Natural Killer T-Cells, Receptors, Antigen, T-Cell, Glycolipids, Antigens, CD1d. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
In this issue of JEM, Hosono et al. (https://doi.org/10.1084/jem.20240728) characterize a putative self- glycolipid that engages the iNKT cell TCR when bound to CD1d. The expression and distribution of this compound helps to explain some of the unusual properties of invariant NKT cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- La Jolla Institute for Immunology , La Jolla, CA, USA.
- Department of Molecular Biology, University of California San Diego, La Jolla, CA, USA.
ORCID-Profile: Mitchell Kronenberg, Gabriel Ascui
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kronenberg, M., & Ascui, G. (2025). The α glycolipid rules the NKT cell TCR. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20242099
Vancouver
Kronenberg M, Ascui G. The α glycolipid rules the NKT cell TCR. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20242099
BibTeX
@article{Kronenberg2025,
author = {Kronenberg, Mitchell and Ascui, Gabriel},
title = {The α glycolipid rules the NKT cell TCR},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20242099}
}
EUVIMED